Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers

Sandra L. Wong, Celia Chao, Michael J. Edwards, Todd M. Tuttle, R. Dirk Noyes, David J. Carlson, Alison L. Laidley, Terre Q. Mcglothin, Philip B. Ley, C. Matthew Brown, Rebecca L. Glaser, Robert E. Pennington, Peter S. Turk, Diana Simpson, Kelly M. McMasters

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Although numerous studies have demonstrated that sentinel lymph node (SLN) biopsy can accurately determine the axillary nodal status for early breast cancer some studies have suggested that SLN biopsy may be less reliable for tumors >2 cm in size. This analysis was performed to determine whether tumor size affects the accuracy of SLN biopsy. The University of Louisville Breast Cancer Sentinel Lymph Node Study is a prospective multi-institutional study involving 226 surgeons. The study was approved by the Institutional Review Board of each institution, and informed consent was obtained from all patients. Patients with clinical stage T1-2 N0 breast cancer were eligible for the study. Some patients with T3 tumors were included because they were clinically staged as T2 but on final pathology were found to have tumors >5 cm. This analysis includes 2148 patients who were enrolled from August 1997 through October 2000. All patients underwent SLN biopsy using a combination of radioactive colloid and blue dye injection followed by completion Level I/II axillary dissection. Statistical comparison was performed by chi-square analysis. The SLN identification rate, false negative rate, and overall accuracy of SLN biopsy were not significantly different among tumor stages T1, T2, and T3. We conclude that SLN biopsy is no less accurate for T2-3 breast cancers compared with T1 tumors.

Original languageEnglish (US)
Pages (from-to)522-526
Number of pages5
JournalAmerican Surgeon
Volume67
Issue number6
StatePublished - 2001
Externally publishedYes

Fingerprint

Sentinel Lymph Node Biopsy
Breast Neoplasms
Neoplasms
Research Ethics Committees
Colloids
Informed Consent
Dissection
Coloring Agents
Pathology
Injections

ASJC Scopus subject areas

  • Surgery

Cite this

Wong, S. L., Chao, C., Edwards, M. J., Tuttle, T. M., Noyes, R. D., Carlson, D. J., ... McMasters, K. M. (2001). Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. American Surgeon, 67(6), 522-526.

Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. / Wong, Sandra L.; Chao, Celia; Edwards, Michael J.; Tuttle, Todd M.; Noyes, R. Dirk; Carlson, David J.; Laidley, Alison L.; Mcglothin, Terre Q.; Ley, Philip B.; Brown, C. Matthew; Glaser, Rebecca L.; Pennington, Robert E.; Turk, Peter S.; Simpson, Diana; McMasters, Kelly M.

In: American Surgeon, Vol. 67, No. 6, 2001, p. 522-526.

Research output: Contribution to journalArticle

Wong, SL, Chao, C, Edwards, MJ, Tuttle, TM, Noyes, RD, Carlson, DJ, Laidley, AL, Mcglothin, TQ, Ley, PB, Brown, CM, Glaser, RL, Pennington, RE, Turk, PS, Simpson, D & McMasters, KM 2001, 'Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers', American Surgeon, vol. 67, no. 6, pp. 522-526.
Wong SL, Chao C, Edwards MJ, Tuttle TM, Noyes RD, Carlson DJ et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. American Surgeon. 2001;67(6):522-526.
Wong, Sandra L. ; Chao, Celia ; Edwards, Michael J. ; Tuttle, Todd M. ; Noyes, R. Dirk ; Carlson, David J. ; Laidley, Alison L. ; Mcglothin, Terre Q. ; Ley, Philip B. ; Brown, C. Matthew ; Glaser, Rebecca L. ; Pennington, Robert E. ; Turk, Peter S. ; Simpson, Diana ; McMasters, Kelly M. / Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. In: American Surgeon. 2001 ; Vol. 67, No. 6. pp. 522-526.
@article{0c329febf07241018c63005415203c01,
title = "Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers",
abstract = "Although numerous studies have demonstrated that sentinel lymph node (SLN) biopsy can accurately determine the axillary nodal status for early breast cancer some studies have suggested that SLN biopsy may be less reliable for tumors >2 cm in size. This analysis was performed to determine whether tumor size affects the accuracy of SLN biopsy. The University of Louisville Breast Cancer Sentinel Lymph Node Study is a prospective multi-institutional study involving 226 surgeons. The study was approved by the Institutional Review Board of each institution, and informed consent was obtained from all patients. Patients with clinical stage T1-2 N0 breast cancer were eligible for the study. Some patients with T3 tumors were included because they were clinically staged as T2 but on final pathology were found to have tumors >5 cm. This analysis includes 2148 patients who were enrolled from August 1997 through October 2000. All patients underwent SLN biopsy using a combination of radioactive colloid and blue dye injection followed by completion Level I/II axillary dissection. Statistical comparison was performed by chi-square analysis. The SLN identification rate, false negative rate, and overall accuracy of SLN biopsy were not significantly different among tumor stages T1, T2, and T3. We conclude that SLN biopsy is no less accurate for T2-3 breast cancers compared with T1 tumors.",
author = "Wong, {Sandra L.} and Celia Chao and Edwards, {Michael J.} and Tuttle, {Todd M.} and Noyes, {R. Dirk} and Carlson, {David J.} and Laidley, {Alison L.} and Mcglothin, {Terre Q.} and Ley, {Philip B.} and Brown, {C. Matthew} and Glaser, {Rebecca L.} and Pennington, {Robert E.} and Turk, {Peter S.} and Diana Simpson and McMasters, {Kelly M.}",
year = "2001",
language = "English (US)",
volume = "67",
pages = "522--526",
journal = "The American surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "6",

}

TY - JOUR

T1 - Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers

AU - Wong, Sandra L.

AU - Chao, Celia

AU - Edwards, Michael J.

AU - Tuttle, Todd M.

AU - Noyes, R. Dirk

AU - Carlson, David J.

AU - Laidley, Alison L.

AU - Mcglothin, Terre Q.

AU - Ley, Philip B.

AU - Brown, C. Matthew

AU - Glaser, Rebecca L.

AU - Pennington, Robert E.

AU - Turk, Peter S.

AU - Simpson, Diana

AU - McMasters, Kelly M.

PY - 2001

Y1 - 2001

N2 - Although numerous studies have demonstrated that sentinel lymph node (SLN) biopsy can accurately determine the axillary nodal status for early breast cancer some studies have suggested that SLN biopsy may be less reliable for tumors >2 cm in size. This analysis was performed to determine whether tumor size affects the accuracy of SLN biopsy. The University of Louisville Breast Cancer Sentinel Lymph Node Study is a prospective multi-institutional study involving 226 surgeons. The study was approved by the Institutional Review Board of each institution, and informed consent was obtained from all patients. Patients with clinical stage T1-2 N0 breast cancer were eligible for the study. Some patients with T3 tumors were included because they were clinically staged as T2 but on final pathology were found to have tumors >5 cm. This analysis includes 2148 patients who were enrolled from August 1997 through October 2000. All patients underwent SLN biopsy using a combination of radioactive colloid and blue dye injection followed by completion Level I/II axillary dissection. Statistical comparison was performed by chi-square analysis. The SLN identification rate, false negative rate, and overall accuracy of SLN biopsy were not significantly different among tumor stages T1, T2, and T3. We conclude that SLN biopsy is no less accurate for T2-3 breast cancers compared with T1 tumors.

AB - Although numerous studies have demonstrated that sentinel lymph node (SLN) biopsy can accurately determine the axillary nodal status for early breast cancer some studies have suggested that SLN biopsy may be less reliable for tumors >2 cm in size. This analysis was performed to determine whether tumor size affects the accuracy of SLN biopsy. The University of Louisville Breast Cancer Sentinel Lymph Node Study is a prospective multi-institutional study involving 226 surgeons. The study was approved by the Institutional Review Board of each institution, and informed consent was obtained from all patients. Patients with clinical stage T1-2 N0 breast cancer were eligible for the study. Some patients with T3 tumors were included because they were clinically staged as T2 but on final pathology were found to have tumors >5 cm. This analysis includes 2148 patients who were enrolled from August 1997 through October 2000. All patients underwent SLN biopsy using a combination of radioactive colloid and blue dye injection followed by completion Level I/II axillary dissection. Statistical comparison was performed by chi-square analysis. The SLN identification rate, false negative rate, and overall accuracy of SLN biopsy were not significantly different among tumor stages T1, T2, and T3. We conclude that SLN biopsy is no less accurate for T2-3 breast cancers compared with T1 tumors.

UR - http://www.scopus.com/inward/record.url?scp=0035377667&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035377667&partnerID=8YFLogxK

M3 - Article

C2 - 11409798

AN - SCOPUS:0035377667

VL - 67

SP - 522

EP - 526

JO - The American surgeon

JF - The American surgeon

SN - 0003-1348

IS - 6

ER -